| ITGAE |
ITGAE: Integrin alpha-E precursor |
FLT3 |
FLT3, STK1: FL cytokine receptor precursor |
0.265 |
Evidence |
|
| BRCA2 |
BRCA2, FACD, FANCD1: Breast cancer type 2 susceptibility protein |
WRN |
WRN, RECQ3, RECQL2: Werner syndrome ATP-dependent helicase |
0.265 |
Evidence |
|
| HMGN2 |
HMGN2, HMG17: Non-histone chromosomal protein HMG-17 |
STK10 |
STK10: Uncharacterized protein STK10 |
0.265 |
Evidence |
|
| SGK3 |
SGK3, SGK2, SGKL: Serine/threonine-protein kinase Sgk3 |
APPL |
APPL1, APPL, DIP13A, KIAA1428: DCC-interacting protein 13-alpha |
0.265 |
Evidence |
|
| OSBP |
OSBP, OSBP1: Oxysterol-binding protein 1 |
MAPKAPK2 |
MAPKAPK2: MAP kinase-activated protein kinase 2 |
0.265 |
Evidence |
|
| GRAP2 |
GRAP2, GADS, GRB2L, GRID: GRB2-related adapter protein 2 |
PSCD4 |
PSCD4, CYT4: Cytohesin-4 |
0.265 |
Evidence |
|
| HSF2 |
HSF2, HSTF2: Heat shock factor protein 2 |
BATF |
BATF: Basic leucine zipper transcriptional factor ATF-like |
0.265 |
Evidence |
|
| C1S |
C1S: Complement C1s subcomponent precursor |
CCL14 |
CCL14, NCC2, SCYA14: Small-inducible cytokine A14 precursor |
0.265 |
Evidence |
|
| MAP3K8 |
MAP3K8, COT, ESTF: Mitogen-activated protein kinase kinase kinase 8 |
IQGAP2 |
IQGAP2: Ras GTPase-activating-like protein IQGAP2 |
0.265 |
Evidence |
|
| COL3A1 |
COL3A1: Collagen alpha-1(III) chain precursor |
TNC |
TNC, HXB: Tenascin precursor |
0.265 |
Evidence |
|
| SCRIB |
SCRIB, CRIB1, KIAA0147, LAP4, SCRB1, VARTUL: Protein LAP4 |
TRADD |
TRADD: Tumor necrosis factor receptor type 1-associated DEATH domain protein |
0.265 |
Evidence |
|
| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
0.265 |
Evidence |
|
| ARPC1B |
ARC41, ARPC1B: Actin-related protein 2/3 complex subunit 1B |
JMJD1A |
JMJD1A, JHDM2A, JMJD1, KIAA0742: JmjC domain-containing histone demethylation pr |
0.265 |
Evidence |
|
| TERF1 |
TERF1, PIN2, TRBF1, TRF, TRF1: Telomeric repeat-binding factor 1 |
GCN5L2 |
GCN5L2, GCN5, HGCN5: General control of amino acid synthesis protein 5-like 2 |
0.265 |
Evidence |
|
| THBD |
THBD, THRM: Thrombomodulin precursor |
BCAM |
BCAM, LU, MSK19: Lutheran blood group glycoprotein precursor |
0.265 |
Evidence |
|
| OSBPL11 |
OSBPL11, ORP11, OSBP12: Oxysterol-binding protein-related protein 11 |
SCYL3 |
SCYL3, PACE1: Protein-associating with the carboxyl-terminal domain of ezrin |
0.265 |
Evidence |
|
| ADRBK1 |
ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 |
SLA |
SLA, SLAP, SLAP1: SRC-like-adapter |
0.265 |
Evidence |
|
| SFRS15 |
SFRS15, KIAA1172: Splicing factor, arginine/serine-rich 15 |
ZCCHC8 |
ZCCHC8: Zinc finger CCHC domain-containing protein 8 |
0.265 |
Evidence |
|
| FOXO1A |
FOXO1A, FKHR: Forkhead box protein O1A |
IRF3 |
IRF3: Interferon regulatory factor 3 |
0.265 |
Evidence |
|
| XRCC6 |
XRCC6, G22P1: ATP-dependent DNA helicase 2 subunit 1 |
PIK3CG |
PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i |
0.265 |
Evidence |
|
| MAP2K4 |
MAP2K4, JNKK1, MKK4, PRKMK4, SERK1: Dual specificity mitogen-activated protein k |
GAB2 |
IPI00186990 |
0.265 |
Evidence |
|
| ESR1 |
ESR1, ESR, NR3A1: Estrogen receptor |
PGR |
PGR, NR3C3: Progesterone receptor |
0.265 |
Evidence |
|
| PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
LAMA2 |
LAMA2: Uncharacterized protein LAMA2 |
0.265 |
Evidence |
|
| PLCG1 |
PLCG1, PLC1: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 |
STK10 |
STK10: Uncharacterized protein STK10 |
0.265 |
Evidence |
|
| PSTPIP1 |
PSTPIP1, CD2BP1: Proline-serine-threonine phosphatase-interacting protein 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
0.265 |
Evidence |
|
- 
- 
-